<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36010557</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>29</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>26</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>16</Issue><PubDate><Year>2022</Year><Month>Aug</Month><Day>10</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Neuro-Axonal Damage and Alteration of Blood-Brain Barrier Integrity in COVID-19 Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2480</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells11162480</ELocationID><Abstract><AbstractText>Neurofilament light chain (NfL) is a specific biomarker of neuro-axonal damage. Matrix metalloproteinases (MMPs) are zinc-dependent enzymes involved in blood-brain barrier (BBB) integrity. We explored neuro-axonal damage, alteration of BBB integrity and SARS-CoV-2 RNA presence in COVID-19 patients with severe neurological symptoms (neuro-COVID) as well as neuro-axonal damage in COVID-19 patients without severe neurological symptoms according to disease severity and after recovery, comparing the obtained findings with healthy donors (HD). Overall, COVID-19 patients (<i>n</i> = 55) showed higher plasma NfL levels compared to HD (<i>n</i> = 31) (<i>p</i> &lt; 0.0001), especially those who developed ARDS (<i>n</i> = 28) (<i>p</i> = 0.0005). After recovery, plasma NfL levels were still higher in ARDS patients compared to HD (<i>p</i> = 0.0037). In neuro-COVID patients (<i>n</i> = 12), higher CSF and plasma NfL, and CSF MMP-2 levels in ARDS than non-ARDS group were observed (<i>p</i> = 0.0357, <i>p</i> = 0.0346 and <i>p</i> = 0.0303, respectively). SARS-CoV-2 RNA was detected in four CSF and two plasma samples. SARS-CoV-2 RNA detection was not associated to increased CSF NfL and MMP levels. During COVID-19, ARDS could be associated to CNS damage and alteration of BBB integrity in the absence of SARS-CoV-2 RNA detection in CSF or blood. CNS damage was still detectable after discharge in blood of COVID-19 patients who developed ARDS during hospitalization.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zingaropoli</LastName><ForeName>Maria Antonella</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iannetta</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6938-8627</Identifier><AffiliationInfo><Affiliation>Department of Systems Medicine, Tor Vergata University of Rome, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piermatteo</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Experimental Medicine, Tor Vergata University of Rome, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pasculli</LastName><ForeName>Patrizia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Latronico</LastName><ForeName>Tiziana</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari Aldo Moro, 70126 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzuti</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Clinical and Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campogiani</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Systems Medicine, Tor Vergata University of Rome, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duca</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Experimental Medicine, Tor Vergata University of Rome, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferraguti</LastName><ForeName>Giampiero</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-6129-4071</Identifier><AffiliationInfo><Affiliation>Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Michele</LastName><ForeName>Manuela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Emergency Department Stroke Unit, Department of Human Neurosciences, Sapienza University of Rome, 00161 Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Galardo</LastName><ForeName>Gioacchino</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-5941-9947</Identifier><AffiliationInfo><Affiliation>Medical Emergency Unit, Sapienza University of Rome, Policlinico Umberto I, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pugliese</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0002-8076-1250</Identifier><AffiliationInfo><Affiliation>Department of Specialist Surgery and Organ Transplantation "Paride Stefanini", Policlinico Umberto I, Sapienza University of Rome, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antonelli</LastName><ForeName>Guido</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreoni</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Systems Medicine, Tor Vergata University of Rome, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sarmati</LastName><ForeName>Loredana</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1452-0333</Identifier><AffiliationInfo><Affiliation>Department of Systems Medicine, Tor Vergata University of Rome, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lichtner</LastName><ForeName>Miriam</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases Unit, SM Goretti Hospital, Sapienza University of Rome, 04100 Latina, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Turriziani</LastName><ForeName>Ombretta</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0001-6400-9168</Identifier><AffiliationInfo><Affiliation>Department of Molecular Medicine, Sapienza University of Rome, 00161 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ceccherini-Silberstein</LastName><ForeName>Francesca</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Experimental Medicine, Tor Vergata University of Rome, 00133 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liuzzi</LastName><ForeName>Grazia Maria</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Biosciences, Biotechnologies and Biopharmaceutics, University of Bari Aldo Moro, 70126 Bari, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mastroianni</LastName><ForeName>Claudio Maria</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0002-1286-467X</Identifier><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ciardi</LastName><ForeName>Maria Rosa</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>08</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001369" MajorTopicYN="N">Axons</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001812" MajorTopicYN="Y">Blood-Brain Barrier</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">MMPs</Keyword><Keyword MajorTopicYN="N">NfL</Keyword><Keyword MajorTopicYN="N">ddPCR</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">matrix metalloproteinases</Keyword><Keyword MajorTopicYN="N">neuro-COVID</Keyword><Keyword MajorTopicYN="N">neurofilament light chain</Keyword><Keyword MajorTopicYN="N">zymography</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>8</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>8</Month><Day>26</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>8</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>8</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36010557</ArticleId><ArticleId IdType="pmc">PMC9406414</ArticleId><ArticleId IdType="doi">10.3390/cells11162480</ArticleId><ArticleId IdType="pii">cells11162480</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., Nair N., Mahajan S., Sehrawat T.S., Bikdeli B., Ahluwalia N., Ausiello J.C., Wan E.Y., et al. Extrapulmonary Manifestations of COVID-19. Nat. Med. 2020;26:1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W.-J., Ni Z.-Y., Hu Y., Liang W.-H., Ou C.-Q., He J.-X., Liu L., Shan H., Lei C.-L., Hui D.S.C., et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020;382:1708&#x2013;1720. doi: 10.1056/NEJMoa2002032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S., Qin M., Shen B., Cai Y., Liu T., Yang F., Gong W., Liu X., Liang J., Zhao Q., et al. Association of Cardiac Injury With Mortality in Hospitalized Patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5:802&#x2013;810. doi: 10.1001/jamacardio.2020.0950.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.0950</ArticleId><ArticleId IdType="pmc">PMC7097841</ArticleId><ArticleId IdType="pubmed">32211816</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., et al. Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study. Lancet. 2020;395:1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C., Chen X., Cai Y., Xia J., Zhou X., Xu S., Huang H., Zhang L., Zhou X., Du C., et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients with Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern. Med. 2020;180:934&#x2013;943. doi: 10.1001/jamainternmed.2020.0994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2020.0994</ArticleId><ArticleId IdType="pmc">PMC7070509</ArticleId><ArticleId IdType="pubmed">32167524</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasculli P., Zingaropoli M.A., Masci G.M., Mazzuti L., Perri V., Paribeni F., Russo G., Arcari G., Iafrate F., Vullo F., et al. Chest Computed Tomography Score, Cycle Threshold Values and Secondary Infection in Predicting COVID-19 Mortality. New Microbiol. 2021;44:145&#x2013;154.</Citation><ArticleIdList><ArticleId IdType="pubmed">34783349</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., et al. Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., Wang B., Xiang H., Cheng Z., Xiong Y., et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020;323:1061&#x2013;1069. doi: 10.1001/jama.2020.1585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Lechien J.R., Chiesa-Estomba C.M., De Siati D.R., Horoi M., Le Bon S.D., Rodriguez A., Dequanter D., Blecic S., El Afia F., Distinguin L., et al. Olfactory and Gustatory Dysfunctions as a Clinical Presentation of Mild-to-Moderate Forms of the Coronavirus Disease (COVID-19): A Multicenter European Study. Eur. Arch. Otorhinolaryngol. 2020;277:2251&#x2013;2261. doi: 10.1007/s00405-020-05965-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00405-020-05965-1</ArticleId><ArticleId IdType="pmc">PMC7134551</ArticleId><ArticleId IdType="pubmed">32253535</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinato G., Fabbris C., Polesel J., Cazzador D., Borsetto D., Hopkins C., Boscolo-Rizzo P. Alterations in Smell or Taste in Mildly Symptomatic Outpatients with SARS-CoV-2 Infection. JAMA. 2020;323:2089&#x2013;2090. doi: 10.1001/jama.2020.6771.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6771</ArticleId><ArticleId IdType="pmc">PMC7177631</ArticleId><ArticleId IdType="pubmed">32320008</ArticleId></ArticleIdList></Reference><Reference><Citation>Oxley T.J., Mocco J., Majidi S., Kellner C.P., Shoirah H., Singh I.P., De Leacy R.A., Shigematsu T., Ladner T.R., Yaeger K.A., et al. Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. N. Engl. J. Med. 2020;382:e60. doi: 10.1056/NEJMc2009787.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2009787</ArticleId><ArticleId IdType="pmc">PMC7207073</ArticleId><ArticleId IdType="pubmed">32343504</ArticleId></ArticleIdList></Reference><Reference><Citation>Yaghi S., Ishida K., Torres J., Mac Grory B., Raz E., Humbert K., Henninger N., Trivedi T., Lillemoe K., Alam S., et al. SARS-CoV-2 and Stroke in a New York Healthcare System. Stroke. 2020;51:2002&#x2013;2011. doi: 10.1161/STROKEAHA.120.030335.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.120.030335</ArticleId><ArticleId IdType="pmc">PMC7258764</ArticleId><ArticleId IdType="pubmed">32432996</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan J., Ge J., Yu J., Shan S., Zhou H., Fan S., Zhang Q., Shi X., Wang Q., Zhang L., et al. Structure of the SARS-CoV-2 Spike Receptor-Binding Domain Bound to the ACE2 Receptor. Nature. 2020;581:215&#x2013;220. doi: 10.1038/s41586-020-2180-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2180-5</ArticleId><ArticleId IdType="pubmed">32225176</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei C., Qian K., Li T., Zhang S., Fu W., Ding M., Hu S. Neutralization of SARS-CoV-2 Spike Pseudotyped Virus by Recombinant ACE2-Ig. Nat. Commun. 2020;11:2070. doi: 10.1038/s41467-020-16048-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-16048-4</ArticleId><ArticleId IdType="pmc">PMC7265355</ArticleId><ArticleId IdType="pubmed">32332765</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H., Shen D., Zhou H., Liu J., Chen S. Guillain-Barr&#xe9; Syndrome Associated with SARS-CoV-2 Infection: Causality or Coincidence? Lancet Neurol. 2020;19:383&#x2013;384. doi: 10.1016/S1474-4422(20)30109-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(20)30109-5</ArticleId><ArticleId IdType="pmc">PMC7176927</ArticleId><ArticleId IdType="pubmed">32246917</ArticleId></ArticleIdList></Reference><Reference><Citation>Toscano G., Palmerini F., Ravaglia S., Ruiz L., Invernizzi P., Cuzzoni M.G., Franciotta D., Baldanti F., Daturi R., Postorino P., et al. Guillain-Barr&#xe9; Syndrome Associated with SARS-CoV-2. N. Engl. J. Med. 2020;382:2574&#x2013;2576. doi: 10.1056/NEJMc2009191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2009191</ArticleId><ArticleId IdType="pmc">PMC7182017</ArticleId><ArticleId IdType="pubmed">32302082</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Kremer S., Merdji H., Clere-Jehl R., Schenck M., Kummerlen C., Collange O., Boulay C., Fafi-Kremer S., Ohana M., et al. Neurologic Features in Severe SARS-CoV-2 Infection. N. Engl. J. Med. 2020;382:2268&#x2013;2270. doi: 10.1056/NEJMc2008597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2008597</ArticleId><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Franceschi A.M., Ahmed O., Giliberto L., Castillo M. Hemorrhagic Posterior Reversible Encephalopathy Syndrome as a Manifestation of COVID-19 Infection. AJNR Am. J. Neuroradiol. 2020;41:1173&#x2013;1176. doi: 10.3174/ajnr.A6595.</Citation><ArticleIdList><ArticleId IdType="doi">10.3174/ajnr.A6595</ArticleId><ArticleId IdType="pmc">PMC7357664</ArticleId><ArticleId IdType="pubmed">32439646</ArticleId></ArticleIdList></Reference><Reference><Citation>Moriguchi T., Harii N., Goto J., Harada D., Sugawara H., Takamino J., Ueno M., Sakata H., Kondo K., Myose N., et al. A First Case of Meningitis/Encephalitis Associated with SARS-Coronavirus-2. Int. J. Infect. Dis. 2020;94:55&#x2013;58. doi: 10.1016/j.ijid.2020.03.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.03.062</ArticleId><ArticleId IdType="pmc">PMC7195378</ArticleId><ArticleId IdType="pubmed">32251791</ArticleId></ArticleIdList></Reference><Reference><Citation>Poyiadji N., Shahin G., Noujaim D., Stone M., Patel S., Griffith B. COVID-19-Associated Acute Hemorrhagic Necrotizing Encephalopathy: Imaging Features. Radiology. 2020;296:E119&#x2013;E120. doi: 10.1148/radiol.2020201187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020201187</ArticleId><ArticleId IdType="pmc">PMC7233386</ArticleId><ArticleId IdType="pubmed">32228363</ArticleId></ArticleIdList></Reference><Reference><Citation>Marinho P.M., Marcos A.A.A., Romano A.C., Nascimento H., Belfort R. Retinal Findings in Patients with COVID-19. Lancet. 2020;395:1610. doi: 10.1016/S0140-6736(20)31014-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31014-X</ArticleId><ArticleId IdType="pmc">PMC7217650</ArticleId><ArticleId IdType="pubmed">32405105</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu P., Duan F., Luo C., Liu Q., Qu X., Liang L., Wu K. Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020;138:575&#x2013;578. doi: 10.1001/jamaophthalmol.2020.1291.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaophthalmol.2020.1291</ArticleId><ArticleId IdType="pmc">PMC7110919</ArticleId><ArticleId IdType="pubmed">32232433</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheema M., Aghazadeh H., Nazarali S., Ting A., Hodges J., McFarlane A., Kanji J.N., Zelyas N., Damji K.F., Solarte C. Keratoconjunctivitis as the Initial Medical Presentation of the Novel Coronavirus Disease 2019 (COVID-19) Can. J. Ophthalmol. 2020;55:e125&#x2013;e129. doi: 10.1016/j.jcjo.2020.03.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcjo.2020.03.003</ArticleId><ArticleId IdType="pmc">PMC7124283</ArticleId><ArticleId IdType="pubmed">32284146</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J.-M., Tan B.-H., Wu S., Gui Y., Suo J.-L., Li Y.-C. Evidence of Central Nervous System Infection and Neuroinvasive Routes, as Well as Neurological Involvement, in the Lethality of SARS-CoV-2 Infection. J. Med. Virol. 2021;93:1304&#x2013;1313. doi: 10.1002/jmv.26570.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26570</ArticleId><ArticleId IdType="pmc">PMC7537172</ArticleId><ArticleId IdType="pubmed">33002209</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingues R.B., Lakeman F.D., Mayo M.S., Whitley R.J. Application of Competitive PCR to Cerebrospinal Fluid Samples from Patients with Herpes Simplex Encephalitis. J. Clin. Microbiol. 1998;36:2229&#x2013;2234. doi: 10.1128/JCM.36.8.2229-2234.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.36.8.2229-2234.1998</ArticleId><ArticleId IdType="pmc">PMC105021</ArticleId><ArticleId IdType="pubmed">9665997</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y.H., Jiang D., Huang J.T. SARS-CoV-2 Detected in Cerebrospinal Fluid by PCR in a Case of COVID-19 Encephalitis. Brain Behav. Immun. 2020;87:149. doi: 10.1016/j.bbi.2020.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.05.012</ArticleId><ArticleId IdType="pmc">PMC7202824</ArticleId><ArticleId IdType="pubmed">32387508</ArticleId></ArticleIdList></Reference><Reference><Citation>Kremer S., Lersy F., de S&#xe8;ze J., Ferr&#xe9; J.-C., Maamar A., Carsin-Nicol B., Collange O., Bonneville F., Adam G., Martin-Blondel G., et al. Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study. Radiology. 2020;297:E242&#x2013;E251. doi: 10.1148/radiol.2020202222.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020202222</ArticleId><ArticleId IdType="pmc">PMC7301613</ArticleId><ArticleId IdType="pubmed">32544034</ArticleId></ArticleIdList></Reference><Reference><Citation>Filatov A., Sharma P., Hindi F., Espinosa P.S. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy. Cureus. 2020;12:e7352. doi: 10.7759/cureus.7352.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.7352</ArticleId><ArticleId IdType="pmc">PMC7170017</ArticleId><ArticleId IdType="pubmed">32328364</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaller T., Hirschb&#xfc;hl K., Burkhardt K., Braun G., Trepel M., M&#xe4;rkl B., Claus R. Postmortem Examination of Patients with COVID-19. JAMA. 2020;323:2518&#x2013;2520. doi: 10.1001/jama.2020.8907.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.8907</ArticleId><ArticleId IdType="pmc">PMC7243161</ArticleId><ArticleId IdType="pubmed">32437497</ArticleId></ArticleIdList></Reference><Reference><Citation>Teunissen C.E., Khalil M. Neurofilaments as Biomarkers in Multiple Sclerosis. Mult. Scler. 2012;18:552&#x2013;556. doi: 10.1177/1352458512443092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458512443092</ArticleId><ArticleId IdType="pubmed">22492131</ArticleId></ArticleIdList></Reference><Reference><Citation>Hendricks R., Baker D., Brumm J., Davancaze T., Harp C., Herman A., B&#xfc;dingen H.-C.von, Townsend M., Fischer S.K. Establishment of Neurofilament Light Chain Simoa Assay in Cerebrospinal Fluid and Blood. Bioanalysis. 2019;11:1405&#x2013;1418. doi: 10.4155/bio-2019-0163.</Citation><ArticleIdList><ArticleId IdType="doi">10.4155/bio-2019-0163</ArticleId><ArticleId IdType="pubmed">31401845</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinacker P., Feneberg E., Weishaupt J., Brettschneider J., Tumani H., Andersen P.M., von Arnim C.A.F., B&#xf6;hm S., Kassubek J., Kubisch C., et al. Neurofilaments in the Diagnosis of Motoneuron Diseases: A Prospective Study on 455 Patients. J. Neurol. Neurosurg. Psychiatry. 2016;87:12&#x2013;20. doi: 10.1136/jnnp-2015-311387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-311387</ArticleId><ArticleId IdType="pubmed">26296871</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacs G.G., Andreasson U., Liman V., Regelsberger G., Lutz M.I., Danics K., Keller E., Zetterberg H., Blennow K. Plasma and Cerebrospinal Fluid Tau and Neurofilament Concentrations in Rapidly Progressive Neurological Syndromes: A Neuropathology-Based Cohort. Eur. J. Neurol. 2017;24:1326-e77. doi: 10.1111/ene.13389.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13389</ArticleId><ArticleId IdType="pubmed">28816001</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson A.G.B., Luk C., Heslegrave A.J., Zetterberg H., Mead S.H., Collinge J., Jackson G.S. Neurofilament Light Chain and Tau Concentrations Are Markedly Increased in the Serum of Patients with Sporadic Creutzfeldt-Jakob Disease, and Tau Correlates with Rate of Disease Progression. J. Neurol. Neurosurg. Psychiatry. 2018;89:955&#x2013;961. doi: 10.1136/jnnp-2017-317793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317793</ArticleId><ArticleId IdType="pmc">PMC6109239</ArticleId><ArticleId IdType="pubmed">29487167</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil M., Teunissen C.E., Otto M., Piehl F., Sormani M.P., Gattringer T., Barro C., Kappos L., Comabella M., Fazekas F., et al. Neurofilaments as Biomarkers in Neurological Disorders. Nat. Rev. Neurol. 2018;14:577&#x2013;589. doi: 10.1038/s41582-018-0058-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0058-z</ArticleId><ArticleId IdType="pubmed">30171200</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral-Pacheco G.A., Garza-Veloz I., Castruita-De la Rosa C., Ramirez-Acu&#xf1;a J.M., Perez-Romero B.A., Guerrero-Rodriguez J.F., Martinez-Avila N., Martinez-Fierro M.L. The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases. Int. J. Mol. Sci. 2020;21:9739. doi: 10.3390/ijms21249739.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21249739</ArticleId><ArticleId IdType="pmc">PMC7767220</ArticleId><ArticleId IdType="pubmed">33419373</ArticleId></ArticleIdList></Reference><Reference><Citation>Spindler K.R., Hsu T.-H. Viral Disruption of the Blood-Brain Barrier. Trends Microbiol. 2012;20:282&#x2013;290. doi: 10.1016/j.tim.2012.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2012.03.009</ArticleId><ArticleId IdType="pmc">PMC3367119</ArticleId><ArticleId IdType="pubmed">22564250</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolb S.A., Lahrtz F., Paul R., Leppert D., Nadal D., Pfister H.W., Fontana A. Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Viral Meningitis: Upregulation of MMP-9 and TIMP-1 in Cerebrospinal Fluid. J. Neuroimmunol. 1998;84:143&#x2013;150. doi: 10.1016/S0165-5728(97)00247-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-5728(97)00247-6</ArticleId><ArticleId IdType="pubmed">9628456</ArticleId></ArticleIdList></Reference><Reference><Citation>Lind L., Eriksson K., Grahn A. Chemokines and Matrix Metalloproteinases in Cerebrospinal Fluid of Patients with Central Nervous System Complications Caused by Varicella-Zoster Virus. J. Neuroinflamm. 2019;16:42. doi: 10.1186/s12974-019-1428-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1428-1</ArticleId><ArticleId IdType="pmc">PMC6378740</ArticleId><ArticleId IdType="pubmed">30777092</ArticleId></ArticleIdList></Reference><Reference><Citation>Liuzzi G.M., Mastroianni C.M., Santacroce M.P., Fanelli M., D&#x2019;Agostino C., Vullo V., Riccio P. Increased Activity of Matrix Metalloproteinases in the Cerebrospinal Fluid of Patients with HIV-Associated Neurological Diseases. J. Neurovirol. 2000;6:156&#x2013;163. doi: 10.3109/13550280009013159.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/13550280009013159</ArticleId><ArticleId IdType="pubmed">10822329</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J., Stohlman S.A., Atkinson R., Hinton D.R., Marten N.W. Matrix Metalloproteinase Expression Correlates with Virulence Following Neurotropic Mouse Hepatitis Virus Infection. J. Virol. 2002;76:7374&#x2013;7384. doi: 10.1128/JVI.76.15.7374-7384.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.76.15.7374-7384.2002</ArticleId><ArticleId IdType="pmc">PMC136378</ArticleId><ArticleId IdType="pubmed">12097550</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Carlo D., Mazzuti L., Sciandra I., Guerrizio G., Oliveto G., Riveros Cabral R.J., Zingaropoli M.A., Turriziani O. Comparison of FTD SARS-CoV-2 Assay and RealStar RT-PCR Kit 1.0 for the Detection of SARS-CoV-2. J. Virol. Methods. 2021;298:114276. doi: 10.1016/j.jviromet.2021.114276.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2021.114276</ArticleId><ArticleId IdType="pmc">PMC8420089</ArticleId><ArticleId IdType="pubmed">34499965</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranieri V.M., Rubenfeld G.D., Thompson B.T., Ferguson N.D., Caldwell E., Fan E., Camporota L., Slutsky A.S., ARDS Definition Task Force Acute Respiratory Distress Syndrome: The Berlin Definition. JAMA. 2012;307:2526&#x2013;2533. doi: 10.1001/jama.2012.5669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.5669</ArticleId><ArticleId IdType="pubmed">22797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrazzano G., Zingaropoli M.A., Costanzo M., Belvisi D., Dominelli F., Pasculli P., Ciardi M.R., Fabbrini G., Defazio G., Berardelli A., et al. Neurofilament Assessment in Patients with Cervical Dystonia. Parkinsonism Relat. Disord. 2022;98:70&#x2013;71. doi: 10.1016/j.parkreldis.2022.04.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.parkreldis.2022.04.013</ArticleId><ArticleId IdType="pubmed">35487128</ArticleId></ArticleIdList></Reference><Reference><Citation>Iannetta M., Zingaropoli M.A., Latronico T., Pati I., Pontecorvo S., Prezioso C., Pietropaolo V., Cortese A., Frontoni M., D&#x2019;Agostino C., et al. Dynamic Changes of MMP-9 Plasma Levels Correlate with JCV Reactivation and Immune Activation in Natalizumab-Treated Multiple Sclerosis Patients. Sci. Rep. 2019;9:311. doi: 10.1038/s41598-018-36535-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-36535-5</ArticleId><ArticleId IdType="pmc">PMC6342994</ArticleId><ArticleId IdType="pubmed">30670793</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliva A., Cancelli F., Brogi A., Curtolo A., Savelloni G., Siccardi G., Marcelli G., Mazzuti L., Ricci P., Turriziani O., et al. Convalescent Plasma for Haematological Patients with SARS-CoV-2 Pneumonia and Severe Depletion of B-Cell Lymphocytes Following Anti-CD20 Therapy: A Single-Centre Experience and Review of the Literature. New Microbiol. 2022;45:62&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pubmed">35403848</ArticleId></ArticleIdList></Reference><Reference><Citation>Alteri C., Cento V., Antonello M., Colagrossi L., Merli M., Ughi N., Renica S., Matarazzo E., Di Ruscio F., Tartaglione L., et al. Detection and Quantification of SARS-CoV-2 by Droplet Digital PCR in Real-Time PCR Negative Nasopharyngeal Swabs from Suspected COVID-19 Patients. PLoS ONE. 2020;15:e0236311. doi: 10.1371/journal.pone.0236311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0236311</ArticleId><ArticleId IdType="pmc">PMC7478621</ArticleId><ArticleId IdType="pubmed">32898153</ArticleId></ArticleIdList></Reference><Reference><Citation>Scutari R., Piermatteo L., Ciancio Manuelli M., Iannetta M., Salpini R., Bertoli A., Alteri C., Saccomandi P., Bellocchi M.C., Malagnino V., et al. Long-Term SARS-CoV-2 Infection Associated with Viral Dissemination in Different Body Fluids Including Bile in Two Patients with Acute Cholecystitis. Life. 2020;10:302. doi: 10.3390/life10110302.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/life10110302</ArticleId><ArticleId IdType="pmc">PMC7700357</ArticleId><ArticleId IdType="pubmed">33238410</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M., Hu Y., Chen S., He Q., Chang J., Hong C., Zhou Y., Wang D., et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77:683&#x2013;690. doi: 10.1001/jamaneurol.2020.1127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A., Thomas N., Ellul M.A., Davies N.W.S., Pollak T.A., Tenorio E.L., Sultan M., Easton A., Breen G., Zandi M., et al. Neurological and Neuropsychiatric Complications of COVID-19 in 153 Patients: A UK-Wide Surveillance Study. Lancet Psychiatry. 2020;7:875&#x2013;882. doi: 10.1016/S2215-0366(20)30287-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30287-X</ArticleId><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Nauen D.W., Hooper J.E., Stewart C.M., Solomon I.H. Assessing Brain Capillaries in Coronavirus Disease 2019. JAMA Neurol. 2021;78:760&#x2013;762. doi: 10.1001/jamaneurol.2021.0225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2021.0225</ArticleId><ArticleId IdType="pmc">PMC7881367</ArticleId><ArticleId IdType="pubmed">33576767</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberti P., Beretta S., Piatti M., Karantzoulis A., Piatti M.L., Santoro P., Vigan&#xf2; M., Giovannelli G., Pirro F., Montisano D.A., et al. Guillain-Barr&#xe9; Syndrome Related to COVID-19 Infection. Neurol. Neuroimmunol. Neuroinflamm. 2020;7:e741. doi: 10.1212/NXI.0000000000000741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXI.0000000000000741</ArticleId><ArticleId IdType="pmc">PMC7217652</ArticleId><ArticleId IdType="pubmed">32350026</ArticleId></ArticleIdList></Reference><Reference><Citation>Kananeh M.F., Thomas T., Sharma K., Herpich F., Urtecho J., Athar M.K., Jabbour P., Shah S.O. Arterial and Venous Strokes in the Setting of COVID-19. J. Clin. Neurosci. 2020;79:60&#x2013;66. doi: 10.1016/j.jocn.2020.07.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2020.07.005</ArticleId><ArticleId IdType="pmc">PMC7340078</ArticleId><ArticleId IdType="pubmed">33070919</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lorenzo R., Lor&#xe9; N.I., Finardi A., Mandelli A., Cirillo D.M., Tresoldi C., Benedetti F., Ciceri F., Rovere-Querini P., Comi G., et al. Blood Neurofilament Light Chain and Total Tau Levels at Admission Predict Death in COVID-19 Patients. J. Neurol. 2021;268:4436&#x2013;4442. doi: 10.1007/s00415-021-10595-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10595-6</ArticleId><ArticleId IdType="pmc">PMC8108733</ArticleId><ArticleId IdType="pubmed">33973106</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutter R., Hert L., De Marchis G.M., Twerenbold R., Kappos L., Naegelin Y., Kuster G.M., Benkert P., Jost J., Maceski A.M., et al. Serum Neurofilament Light Chain Levels in the Intensive Care Unit: Comparison between Severely Ill Patients with and without Coronavirus Disease 2019. Ann. Neurol. 2021;89:610&#x2013;616. doi: 10.1002/ana.26004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26004</ArticleId><ArticleId IdType="pubmed">33377539</ArticleId></ArticleIdList></Reference><Reference><Citation>Aamodt A.H., H&#xf8;gest&#xf8;l E.A., Popperud T.H., Holter J.C., Dyrhol-Riise A.M., Tonby K., Stiksrud B., Quist-Paulsen E., Berge T., Barratt-Due A., et al. Blood Neurofilament Light Concentration at Admittance: A Potential Prognostic Marker in COVID-19. J. Neurol. 2021;268:3574&#x2013;3583. doi: 10.1007/s00415-021-10517-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10517-6</ArticleId><ArticleId IdType="pmc">PMC7980743</ArticleId><ArticleId IdType="pubmed">33743046</ArticleId></ArticleIdList></Reference><Reference><Citation>Masvekar R.R., Kosa P., Jin K., Dobbs K., Stack M.A., Castagnoli R., Quaresima V., Su H.C., Imberti L., Notarangelo L.D., et al. Prognostic Value of Serum/Plasma Neurofilament Light Chain for COVID-19 Associated Mortality. medRxiv. 2022;9:622&#x2013;632. doi: 10.1002/acn3.51542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51542</ArticleId><ArticleId IdType="pmc">PMC9082006</ArticleId><ArticleId IdType="pubmed">35313387</ArticleId></ArticleIdList></Reference><Reference><Citation>Manouchehrinia A., Piehl F., Hillert J., Kuhle J., Alfredsson L., Olsson T., Kockum I. Confounding Effect of Blood Volume and Body Mass Index on Blood Neurofilament Light Chain Levels. Ann. Clin. Transl. Neurol. 2020;7:139&#x2013;143. doi: 10.1002/acn3.50972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.50972</ArticleId><ArticleId IdType="pmc">PMC6952306</ArticleId><ArticleId IdType="pubmed">31893563</ArticleId></ArticleIdList></Reference><Reference><Citation>Nilsson I.A.K., Millischer V., Karrenbauer V.D., Jur&#xe9;us A., Salehi A.M., Norring C., von Hausswolff-Juhlin Y., Schalling M., Blennow K., Bulik C.M., et al. Plasma Neurofilament Light Chain Concentration Is Increased in Anorexia Nervosa. Transl. Psychiatry. 2019;9:180. doi: 10.1038/s41398-019-0518-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-019-0518-2</ArticleId><ArticleId IdType="pmc">PMC6675786</ArticleId><ArticleId IdType="pubmed">31371701</ArticleId></ArticleIdList></Reference><Reference><Citation>Akamine S., Marutani N., Kanayama D., Gotoh S., Maruyama R., Yanagida K., Sakagami Y., Mori K., Adachi H., Kozawa J., et al. Renal Function Is Associated with Blood Neurofilament Light Chain Level in Older Adults. Sci. Rep. 2020;10:20350. doi: 10.1038/s41598-020-76990-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-76990-7</ArticleId><ArticleId IdType="pmc">PMC7683708</ArticleId><ArticleId IdType="pubmed">33230211</ArticleId></ArticleIdList></Reference><Reference><Citation>Thota R.N., Chatterjee P., Pedrini S., Hone E., Ferguson J.J.A., Garg M.L., Martins R.N. Association of Plasma Neurofilament Light Chain With Glycaemic Control and Insulin Resistance in Middle-Aged Adults. Front. Endocrinol. 2022;13:915449. doi: 10.3389/fendo.2022.915449.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2022.915449</ArticleId><ArticleId IdType="pmc">PMC9251066</ArticleId><ArticleId IdType="pubmed">35795150</ArticleId></ArticleIdList></Reference><Reference><Citation>Koini M., Pirpamer L., Hofer E., Buchmann A., Pinter D., Ropele S., Enzinger C., Benkert P., Leppert D., Kuhle J., et al. Factors Influencing Serum Neurofilament Light Chain Levels in Normal Aging. Aging. 2021;13:25729&#x2013;25738. doi: 10.18632/aging.203790.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.203790</ArticleId><ArticleId IdType="pmc">PMC8751593</ArticleId><ArticleId IdType="pubmed">34923481</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman P.N., Cleveland D.W., Griffin J.W., Landes P.W., Cowan N.J., Price D.L. Neurofilament Gene Expression: A Major Determinant of Axonal Caliber. Proc. Natl. Acad. Sci. USA. 1987;84:3472&#x2013;3476. doi: 10.1073/pnas.84.10.3472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.84.10.3472</ArticleId><ArticleId IdType="pmc">PMC304893</ArticleId><ArticleId IdType="pubmed">3472217</ArticleId></ArticleIdList></Reference><Reference><Citation>Norgren N., Rosengren L., Stigbrand T. Elevated Neurofilament Levels in Neurological Diseases. Brain Res. 2003;987:25&#x2013;31. doi: 10.1016/S0006-8993(03)03219-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(03)03219-0</ArticleId><ArticleId IdType="pubmed">14499942</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson T., Barcellos L.F., Alfredsson L. Interactions between Genetic, Lifestyle and Environmental Risk Factors for Multiple Sclerosis. Nat. Rev. Neurol. 2017;13:25&#x2013;36. doi: 10.1038/nrneurol.2016.187.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.187</ArticleId><ArticleId IdType="pubmed">27934854</ArticleId></ArticleIdList></Reference><Reference><Citation>Skillb&#xe4;ck T., Farahmand B., Bartlett J.W., Ros&#xe9;n C., Mattsson N., N&#xe4;gga K., Kilander L., Religa D., Wimo A., Winblad B., et al. CSF Neurofilament Light Differs in Neurodegenerative Diseases and Predicts Severity and Survival. Neurology. 2014;83:1945&#x2013;1953. doi: 10.1212/WNL.0000000000001015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001015</ArticleId><ArticleId IdType="pubmed">25339208</ArticleId></ArticleIdList></Reference><Reference><Citation>Karantali E., Kazis D., Chatzikonstantinou S., Petridis F., Mavroudis I. The Role of Neurofilament Light Chain in Frontotemporal Dementia: A Meta-Analysis. Aging Clin. Exp. Res. 2021;33:869&#x2013;881. doi: 10.1007/s40520-020-01554-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-020-01554-8</ArticleId><ArticleId IdType="pubmed">32306372</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalil A.C., Patterson T.F., Mehta A.K., Tomashek K.M., Wolfe C.R., Ghazaryan V., Marconi V.C., Ruiz-Palacios G.M., Hsieh L., Kline S., et al. Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. N. Engl. J. Med. 2021;384:795&#x2013;807. doi: 10.1056/NEJMoa2031994.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2031994</ArticleId><ArticleId IdType="pmc">PMC7745180</ArticleId><ArticleId IdType="pubmed">33306283</ArticleId></ArticleIdList></Reference><Reference><Citation>Hampshire A., Chatfield D.A., MPhil A.M., Jolly A., Trender W., Hellyer P.J., Giovane M.D., Newcombe V.F.J., Outtrim J.G., Warne B., et al. Multivariate Profile and Acute-Phase Correlates of Cognitive Deficits in a COVID-19 Hospitalised Cohort. EClinicalMedicine. 2022;47:101417. doi: 10.1016/j.eclinm.2022.101417.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101417</ArticleId><ArticleId IdType="pmc">PMC9048584</ArticleId><ArticleId IdType="pubmed">35505938</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaetani L., Blennow K., Calabresi P., Di Filippo M., Parnetti L., Zetterberg H. Neurofilament Light Chain as a Biomarker in Neurological Disorders. J. Neurol. Neurosurg. Psychiatry. 2019;90:870&#x2013;881. doi: 10.1136/jnnp-2018-320106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-320106</ArticleId><ArticleId IdType="pubmed">30967444</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.-S., Lee W.-J., Wang S.-J., Fuh J.-L. Levels of Plasma Neurofilament Light Chain and Cognitive Function in Patients with Alzheimer or Parkinson Disease. Sci. Rep. 2018;8:17368. doi: 10.1038/s41598-018-35766-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-35766-w</ArticleId><ArticleId IdType="pmc">PMC6255914</ArticleId><ArticleId IdType="pubmed">30478269</ArticleId></ArticleIdList></Reference><Reference><Citation>Romanic A.M., White R.F., Arleth A.J., Ohlstein E.H., Barone F.C. Matrix Metalloproteinase Expression Increases after Cerebral Focal Ischemia in Rats: Inhibition of Matrix Metalloproteinase-9 Reduces Infarct Size. Stroke. 1998;29:1020&#x2013;1030. doi: 10.1161/01.STR.29.5.1020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.29.5.1020</ArticleId><ArticleId IdType="pubmed">9596253</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenberg G.A. Matrix Metalloproteinases in Neuroinflammation. Glia. 2002;39:279&#x2013;291. doi: 10.1002/glia.10108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.10108</ArticleId><ArticleId IdType="pubmed">12203394</ArticleId></ArticleIdList></Reference><Reference><Citation>Gidday J.M., Gasche Y.G., Copin J.-C., Shah A.R., Perez R.S., Shapiro S.D., Chan P.H., Park T.S. Leukocyte-Derived Matrix Metalloproteinase-9 Mediates Blood-Brain Barrier Breakdown and Is Proinflammatory after Transient Focal Cerebral Ischemia. Am. J. Physiol. Heart Circ. Physiol. 2005;289:H558&#x2013;H568. doi: 10.1152/ajpheart.01275.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.01275.2004</ArticleId><ArticleId IdType="pubmed">15764676</ArticleId></ArticleIdList></Reference><Reference><Citation>Planas A.M., Sol&#xe9; S., Justicia C. Expression and Activation of Matrix Metalloproteinase-2 and -9 in Rat Brain after Transient Focal Cerebral Ischemia. Neurobiol. Dis. 2001;8:834&#x2013;846. doi: 10.1006/nbdi.2001.0435.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2001.0435</ArticleId><ArticleId IdType="pubmed">11592852</ArticleId></ArticleIdList></Reference><Reference><Citation>Le N.D., Muri L., Grandgirard D., Kuhle J., Leppert D., Leib S.L. Evaluation of Neurofilament Light Chain in the Cerebrospinal Fluid and Blood as a Biomarker for Neuronal Damage in Experimental Pneumococcal Meningitis. J. Neuroinflamm. 2020;17:293. doi: 10.1186/s12974-020-01966-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-020-01966-3</ArticleId><ArticleId IdType="pmc">PMC7539528</ArticleId><ArticleId IdType="pubmed">33028339</ArticleId></ArticleIdList></Reference><Reference><Citation>Vecil G.G., Larsen P.H., Corley S.M., Herx L.M., Besson A., Goodyer C.G., Yong V.W. Interleukin-1 Is a Key Regulator of Matrix Metalloproteinase-9 Expression in Human Neurons in Culture and Following Mouse Brain Trauma in Vivo. J. Neurosci. Res. 2000;61:212&#x2013;224. doi: 10.1002/1097-4547(20000715)61:2&lt;212::AID-JNR12&gt;3.0.CO;2-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1097-4547(20000715)61:2&lt;212::AID-JNR12&gt;3.0.CO;2-9</ArticleId><ArticleId IdType="pubmed">10878594</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhard S.M., Razak K., Ethell I.M. A Delicate Balance: Role of MMP-9 in Brain Development and Pathophysiology of Neurodevelopmental Disorders. Front. Cell. Neurosci. 2015;9:280. doi: 10.3389/fncel.2015.00280.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00280</ArticleId><ArticleId IdType="pmc">PMC4518323</ArticleId><ArticleId IdType="pubmed">26283917</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellner J., Leib S.L. In Bacterial Meningitis Cortical Brain Damage Is Associated with Changes in Parenchymal MMP-9/TIMP-1 Ratio and Increased Collagen Type IV Degradation. Neurobiol. Dis. 2006;21:647&#x2013;656. doi: 10.1016/j.nbd.2005.09.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2005.09.007</ArticleId><ArticleId IdType="pubmed">16257222</ArticleId></ArticleIdList></Reference><Reference><Citation>Muri L., Leppert D., Grandgirard D., Leib S.L. MMPs and ADAMs in Neurological Infectious Diseases and Multiple Sclerosis. Cell Mol. Life Sci. 2019;76:3097&#x2013;3116. doi: 10.1007/s00018-019-03174-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03174-6</ArticleId><ArticleId IdType="pmc">PMC7079810</ArticleId><ArticleId IdType="pubmed">31172218</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xf6;nbeck U., Mach F., Libby P. Generation of Biologically Active IL-1 Beta by Matrix Metalloproteinases: A Novel Caspase-1-Independent Pathway of IL-1 Beta Processing. J. Immunol. 1998;161:3340&#x2013;3346.</Citation><ArticleIdList><ArticleId IdType="pubmed">9759850</ArticleId></ArticleIdList></Reference><Reference><Citation>Anthony D.C., Miller K.M., Fearn S., Townsend M.J., Opdenakker G., Wells G.M., Clements J.M., Chandler S., Gearing A.J., Perry V.H. Matrix Metalloproteinase Expression in an Experimentally-Induced DTH Model of Multiple Sclerosis in the Rat CNS. J. Neuroimmunol. 1998;87:62&#x2013;72. doi: 10.1016/S0165-5728(98)00046-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-5728(98)00046-0</ArticleId><ArticleId IdType="pubmed">9670846</ArticleId></ArticleIdList></Reference><Reference><Citation>Leppert D., Leib S.L., Grygar C., Miller K.M., Schaad U.B., Holl&#xe4;nder G.A. Matrix Metalloproteinase (MMP)-8 and MMP-9 in Cerebrospinal Fluid during Bacterial Meningitis: Association with Blood-Brain Barrier Damage and Neurological Sequelae. Clin. Infect. Dis. 2000;31:80&#x2013;84. doi: 10.1086/313922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/313922</ArticleId><ArticleId IdType="pubmed">10913401</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakaji K., Ihara M., Takahashi C., Itohara S., Noda M., Takahashi R., Tomimoto H. Matrix Metalloproteinase-2 Plays a Critical Role in the Pathogenesis of White Matter Lesions after Chronic Cerebral Hypoperfusion in Rodents. Stroke. 2006;37:2816&#x2013;2823. doi: 10.1161/01.STR.0000244808.17972.55.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/01.STR.0000244808.17972.55</ArticleId><ArticleId IdType="pubmed">17008622</ArticleId></ArticleIdList></Reference><Reference><Citation>Moseby-Knappe M., Mattsson N., Nielsen N., Zetterberg H., Blennow K., Dankiewicz J., Dragancea I., Friberg H., Lilja G., Insel P.S., et al. Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest. JAMA Neurol. 2019;76:64&#x2013;71. doi: 10.1001/jamaneurol.2018.3223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2018.3223</ArticleId><ArticleId IdType="pmc">PMC6440255</ArticleId><ArticleId IdType="pubmed">30383090</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadhosayni M., Sadat Mohammadi F., Ezzatifar F., Mahdavi Gorabi A., Khosrojerdi A., Aslani S., Hemmatzadeh M., Yazdani S., Arabi M., Marofi F., et al. Matrix Metalloproteinases Are Involved in the Development of Neurological Complications in Patients with Coronavirus Disease 2019. Int. Immunopharmacol. 2021;100:108076. doi: 10.1016/j.intimp.2021.108076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.108076</ArticleId><ArticleId IdType="pmc">PMC8367754</ArticleId><ArticleId IdType="pubmed">34450402</ArticleId></ArticleIdList></Reference><Reference><Citation>Barro C., Chitnis T., Weiner H.L. Blood Neurofilament Light: A Critical Review of Its Application to Neurologic Disease. Ann. Clin. Transl. Neurol. 2020;7:2508&#x2013;2523. doi: 10.1002/acn3.51234.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51234</ArticleId><ArticleId IdType="pmc">PMC7732243</ArticleId><ArticleId IdType="pubmed">33146954</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalm M., Bostr&#xf6;m M., Sandelius &#xc5;., Eriksson Y., Ek C.J., Blennow K., Bj&#xf6;rk-Eriksson T., Zetterberg H. Serum Concentrations of the Axonal Injury Marker Neurofilament Light Protein Are Not Influenced by Blood-Brain Barrier Permeability. Brain Res. 2017;1668:12&#x2013;19. doi: 10.1016/j.brainres.2017.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2017.05.011</ArticleId><ArticleId IdType="pubmed">28522263</ArticleId></ArticleIdList></Reference><Reference><Citation>Uher T., McComb M., Galkin S., Srpova B., Oechtering J., Barro C., Tyblova M., Bergsland N., Krasensky J., Dwyer M., et al. Neurofilament Levels Are Associated with Blood-Brain Barrier Integrity, Lymphocyte Extravasation, and Risk Factors Following the First Demyelinating Event in Multiple Sclerosis. Mult. Scler. 2021;27:220&#x2013;231. doi: 10.1177/1352458520912379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1352458520912379</ArticleId><ArticleId IdType="pubmed">32255388</ArticleId></ArticleIdList></Reference><Reference><Citation>Suo T., Liu X., Feng J., Guo M., Hu W., Guo D., Ullah H., Yang Y., Zhang Q., Wang X., et al. DdPCR: A More Accurate Tool for SARS-CoV-2 Detection in Low Viral Load Specimens. Emerg. Microbes Infect. 2020;9:1259&#x2013;1268. doi: 10.1080/22221751.2020.1772678.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1772678</ArticleId><ArticleId IdType="pmc">PMC7448897</ArticleId><ArticleId IdType="pubmed">32438868</ArticleId></ArticleIdList></Reference><Reference><Citation>Montalvan V., Lee J., Bueso T., De Toledo J., Rivas K. Neurological Manifestations of COVID-19 and Other Coronavirus Infections: A Systematic Review. Clin. Neurol. Neurosurg. 2020;194:105921. doi: 10.1016/j.clineuro.2020.105921.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2020.105921</ArticleId><ArticleId IdType="pmc">PMC7227498</ArticleId><ArticleId IdType="pubmed">32422545</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramani A., M&#xfc;ller L., Ostermann P.N., Gabriel E., Abida-Islam P., M&#xfc;ller-Schiffmann A., Mariappan A., Goureau O., Gruell H., Walker A., et al. SARS-CoV-2 Targets Neurons of 3D Human Brain Organoids. EMBO J. 2020;39:e106230. doi: 10.15252/embj.2020106230.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106230</ArticleId><ArticleId IdType="pmc">PMC7560208</ArticleId><ArticleId IdType="pubmed">32876341</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrini L., Albecka A., Mallery D.L., Kellner M.J., Paul D., Carter A.P., James L.C., Lancaster M.A. SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids. Cell Stem Cell. 2020;27:951&#x2013;961. doi: 10.1016/j.stem.2020.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7553118</ArticleId><ArticleId IdType="pubmed">33113348</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E., Zhang C., Israelow B., Lu-Culligan A., Prado A.V., Skriabine S., Lu P., Weizman O.-E., Liu F., Dai Y., et al. Neuroinvasion of SARS-CoV-2 in Human and Mouse Brain. J. Exp. Med. 2021;218:e20202135. doi: 10.1084/jem.20202135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202135</ArticleId><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia H., Lazartigues E. Angiotensin-Converting Enzyme 2 in the Brain: Properties and Future Directions. J. Neurochem. 2008;107:1482&#x2013;1494. doi: 10.1111/j.1471-4159.2008.05723.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2008.05723.x</ArticleId><ArticleId IdType="pmc">PMC2667944</ArticleId><ArticleId IdType="pubmed">19014390</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumari P., Rothan H.A., Natekar J.P., Stone S., Pathak H., Strate P.G., Arora K., Brinton M.A., Kumar M. Neuroinvasion and Encephalitis Following Intranasal Inoculation of SARS-CoV-2 in K18-HACE2 Mice. Viruses. 2021;13:132. doi: 10.3390/v13010132.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13010132</ArticleId><ArticleId IdType="pmc">PMC7832889</ArticleId><ArticleId IdType="pubmed">33477869</ArticleId></ArticleIdList></Reference><Reference><Citation>Carossino M., Montanaro P., O&#x2019;Connell A., Kenney D., Gertje H., Grosz K., Ericsson M., Huber B.R., Subramaniam S., Kirkland T.A., et al. Fatal Neuroinvasion and SARS-CoV-2 Tropism in K18-HACE2 Mice Is Partially Independent on HACE2 Expression. bioRxiv. 2021;14:535. doi: 10.1101/2021.01.13.425144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.13.425144</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>